Gujarat Terce Laboratories Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was INR 119.05 million compared to INR 107.46 million a year ago. Revenue was INR 119.89 million compared to INR 108.16 million a year ago. Net loss was INR 0.028 million compared to net income of INR 4.77 million a year ago.
For the nine months, sales was INR 338.94 million compared to INR 308.09 million a year ago. Revenue was INR 341.47 million compared to INR 310.23 million a year ago. Net loss was INR 24.75 million compared to net income of INR 25.31 million a year ago. Basic loss per share from continuing operations was INR 3.34 compared to basic earnings per share from continuing operations of INR 3.41 a year ago. Diluted loss per share from continuing operations was INR 3.34 compared to diluted earnings per share from continuing operations of INR 3.41 a year ago.